Dextranomer and Hyaluronate Derivatives (Solesta) and Oxybutynin transdermal
Determining the interaction of Dextranomer and Hyaluronate Derivatives (Solesta) and Oxybutynin transdermal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextranomer / sodium hyaluronate
Brand name: Solesta
Synonyms: Dextranomer and sodium hyaluronate
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextranomer and Hyaluronate Derivatives (Solesta)-Oxybutynin Transdermal System
- Dextranomer and Hyaluronate Derivatives (Solesta)-Oxycodone
- Dextranomer and Hyaluronate Derivatives (Solesta)-Oxycodone and acetaminophen
- Dextranomer and Hyaluronate Derivatives (Solesta)-Oxycodone and Acetaminophen Capsules
- Dextranomer and Hyaluronate Derivatives (Solesta)-Oxycodone and Acetaminophen Capsules and Tablets
- Dextranomer and Hyaluronate Derivatives (Solesta)-Oxycodone and Acetaminophen Extended-Release Tablets
- Oxybutynin transdermal-Dextranomer and sodium hyaluronate
- Oxybutynin transdermal-Dextroamphetamine
- Oxybutynin transdermal-Dextroamphetamine and amphetamine
- Oxybutynin transdermal-Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- Oxybutynin transdermal-Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)
- Oxybutynin transdermal-Dextroamphetamine and Amphetamine Tablets